FDA approves expanded labeling for Medtronic's MRI leads

The U.S. Food and Drug Administration (FDA) has approved expanded labeling for device manufacturer Medtronic's InterStim II and InterStim Micro sacral neuromodulation systems, used with the company's SureScan MRI leads.

The expanded labeling allows for a wider range of MRI scan parameters and shorter wait times between exams, the company said.